Recombinant Mouse API5 Protein
Cat.No. : | API5-1770M |
Product Overview : | Recombinant Mouse API5 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Mouse |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | Api5 apoptosis inhibitor 5 [ Mus musculus ] |
Official Symbol : | API5 |
Gene ID : | 11800 |
mRNA Refseq : | NM_007466.2 |
Protein Refseq : | NP_031492.2 |
MIM : | |
UniProt ID : | O35841 |
Products Types
◆ Recombinant Protein | ||
API5-2310H | Recombinant Human API5 Protein, MYC/DDK-tagged | +Inquiry |
API5-185R | Recombinant Rhesus Macaque API5 Protein, His (Fc)-Avi-tagged | +Inquiry |
Api5-628M | Recombinant Mouse Api5 Protein, MYC/DDK-tagged | +Inquiry |
API5-620M | Recombinant Mouse API5 Protein, His (Fc)-Avi-tagged | +Inquiry |
API5-301104H | Recombinant Human API5 protein, GST-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionThe mutation of API5 gene can be detected by PCR, sequencing, immunohistochemistry and other methods.
Recombinant API5 protein has an important clinical application prospect in prognostic diagnosis, and can provide an important basis for accurate treatment.
Recombinant API5 protein can promote the metastasis of tumor cells and further promote tumor growth and progression.
The specific adverse reactions need to be determined on a case-by-case basis. So far, studies have shown no serious adverse reactions.
Clinical trials can be conducted to evaluate the efficacy of recombinant API5 protein in the treatment of tumors.
Current studies have shown that recombinant API5 protein can play important biological functions in cancer cells and their microenvironment, and has a wide range of therapeutic prospects.
The targeting and specificity of API5 can be improved by constructing targeted drugs, probes, antibodies and other means.
Recombinant API5 protein can enhance the tolerance of tumor cells to radiotherapy by inhibiting apoptosis of tumor cells.
API5 is an inhibitor of apoptosis, which has the function of inhibiting apoptosis in cells and promoting cell survival.
Recombinant API5 proteins can bind to other apoptosis-related cytokines and proteins, thereby regulating cell survival and apoptosis signaling pathways.
Recombinant API5 protein can enhance the effect of tumor immunotherapy by inhibiting the apoptosis of immune cells.
The expression and purification of API5 can be optimized by optimizing the carrier, culture conditions, purification methods and other means.
The stability of API5 in vivo can be improved by building a stable expression system, nucleic acid drug targeting, nanotechnology and other means.
The protein encoded by the API5 gene is composed of 359 amino acids with a molecular weight of about 40kDa and contains a apoptosis inhibition domain (AID) domain.
The expression level of API5 can be detected by Western blot, immunohistochemistry, PCR and other methods.
The recombinant API5 protein can be efficiently delivered to tumor cells by means of nanotechnology, gene transfection, cell delivery, etc.
The pharmacokinetics and toxicology of API5 s can be evaluated through animal studies and in vitro studies.
The biological activity of API5 can be improved by point mutation, structural optimization and sensitivity improvement.
Recombinant API5 protein plays an important role in the occurrence, growth, metastasis and progression of a variety of tumors.
Recombinant API5 proteins can usually be prepared in E. coli or eukaryotic cells by gene recombination techniques.
Customer Reviews (3)
Write a reviewCharacteristics of short half-life and high clearance provide greater potential for recombinant proteins in the treatment of various diseases, and are expected to become a new generation of therapeutic drugs.
The stability of API5 is excellent, and its structure and function remain stable even after multiple freeze-thaw cycles, showing excellent product quality.
Western blot experiments using API5 can obtain very consistent results, indicating its high repeatability and reproducibility.
Ask a Question for All API5 Products
Required fields are marked with *
My Review for All API5 Products
Required fields are marked with *
Inquiry Basket